Aplastic anemia natural history, complications and prognosis

Jump to navigation Jump to search

Aplastic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aplastic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aplastic anemia natural history, complications and prognosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aplastic anemia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aplastic anemia natural history, complications and prognosis

CDC on Aplastic anemia natural history, complications and prognosis

Aplastic anemia natural history, complications and prognosis in the news

Blogs on Aplastic anemia natural history, complications and prognosis

Directions to Hospitals Treating Aplastic anemia

Risk calculators and risk factors for Aplastic anemia natural history, complications and prognosis

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]

Overview

Correct, timely diagnosis with prompt initiation of therapy can increase the survival rates.

Natural History

Untreated aplastic anemia is an illness that leads to rapid death, typically within six months.

Complications

Prognosis

  • Correct and prompt diagnosis with early administration of therapy improves the 5 year survival rate.
  • Occasionally, milder cases of the disease resolve on their own.
  • Relapses of previously controlled disease are, however, much more common.
  • Well-matched bone marrow transplants from siblings have been successful in young, otherwise healthy people, with a long-term survival rate of 80%-90%.
  • Most successful BMT recipients eventually reach a point where they consider themselves cured for all practical purposes, although they need to be compliant with follow-up care permanently.
  • Older people (who are generally too frail to undergo bone marrow transplants) and people who are unable to find a good bone marrow match have five year survival rate of up to 75%.

References